The app is powered by GPT-5.2-Codex, OpenAI’s newest programming-focused large language model. It can process prompts with up ...
Jmail reorganises publicly released Jeffrey Epstein emails into a Gmail-style inbox, making them searchable and easy to navigate. Built by Riley Walz and Luke Igel, the tool improves access to Epstein ...
Horoscope Today February 03, 2026, Tuesday: Today’s market mood mixes caution with selective optimism, placing the spotlight ...
12News is still working to confirm more details.
GeneDx, a fast-growing biotech doing exome and genomic testing, has seen big returns on Wall Street as appetite for its tests grow in the clinic.
WASHINGTON: In the exclusive world of private-company ownership, Kevin Moss is a rare gatekeeper – offering everyday investors exposure to tech giants before they go public.
Background Early graft failure within 90 postoperative days is the leading cause of mortality after heart transplantation. Existing risk scores, based on linear regression, often struggle to capture ...
At a standing committee hearing, Sharma questioned the Ministry of Foreign Affairs on whether Fiji’s diplomatic missions are ...